AIMS AND SCOPE
Chinese Journal of Antituberculosis (Editor-in-Chief: Wang Lixia; ISSN 1000-6621, CN 11-2761/R) is published monthly in Chinese by the Chinese Antituberculosis Association, and is a peer reviewed medical journal for doctors, medical researchers, and health workers in the field of tuberculosis. The journal reports the advances and progress in current tuberculosis sciences and technology.
Scope of the journal
Chinese Journal of Antituberculosis provides a medium for the publication of original research and development work in the field of tuberculosis prevention and treatment. Chinese Journal of Antituberculosis seeks papers in the following topics.
Study on tuberculosis control strategy;
Epidemiological study on tuberculosis;
Study on diagnostic technology of tuberculosis;
Study on Pathogenic Mechanism of Mycobacterium Tuberculosis;
Study on drug resistance mechanism of mycobacterium tuberculosis;
Study on treatment strategy of tuberculosis;
Research on tuberculosis drugs;
Study on drug treatment scheme of tuberculosis;
Research on tuberculosis vaccine;
Study on differential diagnosis of tuberculosis;
Study on the comorbidity of tuberculosis and other diseases;
Study on Pathogenic Mechanism of nontuberculous mycobacterium;
Study on drug resistance mechanism of nontuberculous mycobacterium;
Study on treatment strategy of nontuberculous mycobacterial disease
Reviewer responsibilities
The responsibilities of the reviewer of Chinese Journal of Antituberculosis are summarized as follows:
The reviewer should provide an honest, critical assessment of the research. The reviewer should not manipulate the process to force the authors to address issues interesting or important to the reviewer but peripheral to the objective(s) of the study.
The reviewer should maintain confidentiality about the existence and substance of the manuscript. It is not appropriate to share the manuscript or to discuss it in detail with others or even to reveal the existence of the submission before publication.
The reviewer must not participate in plagiarism. It is obviously a very serious transgression to take data or novel concepts from a paper to advance your own work before the manuscript is published.
The reviewer should always avoid, or disclose, any conflicts of interest. For example, if the reviewer has a close personal or professional relationship with one or more of the authors such that his/her objectivity would be compromised. Scientific merit should be the basis for all reviews.
The reviewer should accept manuscripts for review only in his/her areas of expertise.
The reviewer should agree to review only those manuscripts that can be completed on time. Sometimes, unforeseen circumstances arise that preclude a reviewer from meeting a deadline, but in these instances the reviewer should immediately contact the editor.
The reviewer also has the unpleasant responsibility of reporting suspected duplicate publication, fraud, plagiarism, or ethical concerns about the use of animals or humans in the research being reported.
The reviewer should write reviews in a collegial, constructive manner. This is especially helpful to new investigators. No one likes to have a paper rejected, but a carefully worded review with appropriate suggestions for revision can be very helpful.
Responsibilities and Duties of Editors
The general responsibilities of the editors of Chinese Journal of Antituberculosis are listed below:
Decision on the Publication of Articles. The editors are responsible for deciding which of the articles submitted to the Chinese Journal of Antituberculosis should be published. The editors may be guided by the policies of the journal's editorial board subjected to such legal requirements regarding libel, copyright infringement and plagiarism. The editors may consult with reviewers in making this decision.
Manuscripts shall be evaluated solely on their intellectual merit.
The editors and any editorial staff must not disclose any information about a submitted manuscript to anyone other than the corresponding author, reviewers, potential reviewers, other editorial advisers, and the publisher.
Disclosure and Conflicts of Interest. Unpublished materials disclosed in a submitted manuscript must not be used by anyone who has a view of the manuscript while handling it in his or her own research without the express written consent of the author.
The editors should not hold conflicts of interest with authors whose work they are assessing, e.g. if they are from the same institution or collaborate closely. In this case the Editor-in-Chief or a suitable editorial board member will make final acceptance decisions for submitted papers.
The editors require skills of proofreading, copy editing, developmental editing, line editing and editing for search engine optimization.
It is the responsibility of the editor to reject a piece of writing that appears to be plagiarized or ghost written by another sub-editor. He should check that a particular piece is neither self-plagiarized, nor has been published before elsewhere.
Archiving policy
The journal's website will permanently preserve contents published at least from 1999. If readers find missing papers or inaccessible, please contact us.
Copyright and access
All right reserved by the Chinese Antituberculosis Association.
No content published by the journals of Chinese Antituberculosis Association may be reproduced or abridged without authorization. Please do not use or copy the layout and design of the journals without permission.
All articles published represent the opinions of the authors, and do not reflect the official policy of theChinese Antituberculosis Association or the Editorial Board, unless this is clearly specified.
The ways in which the journal and individual articles are available to readers by subscriptions or pay-per-view fees.
Monthly, Established in Novembar 1934
ISSN 1000-6621
CN 11-2761/R